Nektar Therapeutics (ITH.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:50PM CEST
| Previous close | 1.1730 |
| Open | 1.1450 |
| Bid | 0.0000 x 50000 |
| Ask | 0.0000 x 50000 |
| Day's range | 1.1310 - 1.1450 |
| 52-week range | 0.3901 - 1.6870 |
| Volume | |
| Avg. volume | 841 |
| Market cap | 208.679M |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8500 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.08 |
PR NewswireNektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024
Nektar Therapeutics (Nasdaq: NKTR) today announced the presentation of a poster highlighting new preclinical data on NKTR-0165 at the European Alliance of Associations for Rheumatology (EULAR) 2024 Congress.
Simply Wall St.Nektar Therapeutics' (NASDAQ:NKTR) investors will be pleased with their stellar 130% return over the last year
Nektar Therapeutics ( NASDAQ:NKTR ) shareholders might be concerned after seeing the share price drop 11% in the last...
- PR Newswire
Nektar Management to Present at Upcoming Investor Conferences
Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences:
© 2024 Yahoo. All rights reserved.